Weight-loss jabs can help people with type 2 diabetes control their blood sugar in the long-term, a study has found.
Semaglutide, sold under the brand names Wegovy, Ozempic and Rybelsus, has been hailed as a potential “game changer” in tackling obesity, but can also “significantly” improve blood sugar control and weight loss in diabetics for up to three years, researchers said.
